BEYOND THE ANGIOGRAM: UC Medical Center invests in advanced heart technology
New systems to help cardiologists make more precise and informed treatment decisions.
inside the coronary arteries.
University of Cebu Medical Center (UCMed) is advancing its cardiovascular services with the acquisition of two state-of-the-art technologies designed to improve the assessment and treatment of coronary artery disease.
The VivoHeart Intravascular Ultrasound (IVUS) and the VivoCardio FFR-TruePhysio systems from Biosensors Interventional Technologies allow cardiologists to look beyond conventional angiograms.

While IVUS provides detailed images from inside the coronary arteries, FFR measures pressure differences to determine whether a narrowing significantly restricts blood flow.
Together, these technologies help doctors make better-informed decisions on whether stenting is necessary, guide stent placement, and evaluate treatment results.
“Cardiovascular care continues to evolve, and hospitals must keep pace with advances that can meaningfully improve how physicians diagnose and treat heart disease,” said Dr. Armando V. Tan, UCMed medical director.
Aligned with international clinical guidelines, the investment reflects UCMed’s commitment to bringing advanced, evidence-based heart care closer to patients in Cebu and neighboring communities.
The newly acquired systems are expected to arrive in November 2026.
Informed decisions
Tan said UCMed recognizes the growing international emphasis on intravascular imaging and physiological assessment, particularly in complex coronary interventions.
“Our decision to acquire these technologies comes with our commitment to providing our specialists with more advanced diagnostic and procedural tools,” he pointed out.
The new system provides physicians with a more complete assessment of coronary artery disease, helping them make informed decisions before, during, and after treatment.
Dr. Michael Jeremy Tabaloc, an interventional cardiologist at UCMed, said having both capabilities gives specialists additional information when planning and evaluating coronary interventions.
For UCMed, staying ahead means more than acquiring new equipment. It means preparing its medical team to deliver the kind of cardiovascular care that evolving science and clinical evidence increasingly demand.
examine a patient’s coronary artery at the hospital’s Catheterization Laboratory Unit.

